Probitas Syndicate 1492 has booked a UK GAAP pre-tax profit of £62mn ($83mn) for 2024, an increase of 17% on 2023 and the ...

Probitas 1492 has reported a strong financial performance, with a UK GAAP pretax profit of £62 million in 2024, a 17% increase from 2023. The company’s undiscounted net combined operating ratio (NCOR) ...

Probitas 1492 has reported a strong financial performance, with a UK GAAP pretax profit of £62 million in 2024, a 17% increase from 2023. The company’s undiscounted net combined operating ratio (NCOR) ...

Customer experience solutions provider Concentrix (NASDAQ:CNXC) met Wall Street’s revenue expectations in Q1 CY2025, but ...

Babcock International's strong growth, defense sector gains, and credit upgrade signal a 20% growth by FY2025. See why I rate ...

Office furniture manufacturer MillerKnoll (NASDAQ:MLKN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales ...

Brendan Foley; President, Chief Executive Officer, Director; McCormick & Company Inc Marcos Gabriel; Executive Vice President, Chief Financial Officer; McCormick & Company Inc Good morning. This is ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

Strauss concluded FY 2024 with NIS 752 million in operating profit, 6.7% of the sales, and net profit of NIS 418 million, 3.7% of the sales. In the fourth quarter, operating profit was NIS 174 million ...

As capital becomes more global, the trend to compare the pricing of global companies to local is on the rise. This is especially so in real estate where there are many global REITs that operate in ...

Revenue of $83.0 million, driven primarily by record Interactive revenue, up 45% year-over-yearFourth Quarter Net Income of $68.0 ...

Merck secures global rights to HRS-5346, an investigational Lp(a) inhibitor, in a deal with Hengrui Pharma worth up to $1.97 billion.